CN1054043C - Pharmaceutical composition for treating typhoid fever - Google Patents
Pharmaceutical composition for treating typhoid fever Download PDFInfo
- Publication number
- CN1054043C CN1054043C CN94110874A CN94110874A CN1054043C CN 1054043 C CN1054043 C CN 1054043C CN 94110874 A CN94110874 A CN 94110874A CN 94110874 A CN94110874 A CN 94110874A CN 1054043 C CN1054043 C CN 1054043C
- Authority
- CN
- China
- Prior art keywords
- herba
- typhoid fever
- pharmaceutical composition
- treatment
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000037386 Typhoid Diseases 0.000 title claims abstract description 7
- 201000008297 typhoid fever Diseases 0.000 title claims abstract description 7
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 235000001405 Artemisia annua Nutrition 0.000 abstract 1
- 240000000011 Artemisia annua Species 0.000 abstract 1
- 241000219295 Portulaca Species 0.000 abstract 1
- 240000003705 Senecio vulgaris Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 235000014347 soups Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of powder for treating typhoid fever is prepared from Chinese-medicinal materials including groundsel, sweet wormwood, portulaca, etc. it has the same curative effect in the first, middle and later stages of damp-warm disease, and features short course of treatment, low cost, high cure rate up to 98% or more in three days, and convenient application.
Description
The present invention relates to a kind of people's medication, particularly a kind of Chinese ready made herbal medicine that is used for the treatment of the ileotyphus disease.
At present, the sick main ammonia benzyl Armeniaca mume Sieb. mould (Ampecilline) that adopts of treatment ileotyphus adds 5% glucose saline iv drip, celebrates big syphilis (Getamycin) intramuscular injection, chlorine syphilis tablet (Chloromgcin) or oral three combinations of furaxone (Furazodine) in doctor trained in Western medicine, the course of treatment is longer, generally about ten days, medical expense is than higher." Yang Zhi one symposium on medical topics case collection " the 84th page by Yang Fuguo arrangement, People's Health Publisher's publication, the 1st edition the 1st printing of December in 1981 introduced sanren decoction and the ganlu xiaodu micropills that is used for the treatment of " hygropyrexia " (being ileotyphus), but this soup and this pellet can only be used for the treatment of hygropyrexia (the being ileotyphus) initial stage, for the intermediary and later stages then often can only be as adjuvant therapy medicaments.
The object of the present invention is to provide a kind ofly can be used for just,, back three phase hygropyrexias (being ileotyphus) all have same curative effect and short treating period, medicine that medical expense is low.
The object of the present invention is achieved like this, its composition scope percentage by weight is:
Herba Senecionis Scandentis (Herba Senecionis Seandentis) 1~8%
Herba Artemisiae Annuae (Herba Artemisiae Annuae) 1~8%
Herba Portulacae (Herba Potulacae) 2~10%
Flos Lonicerae (Flos Lonicerae) 9~20%
Fructus Forsythiae (Fructus Forsythine) 9~20%
Herba Lophatheri (Folium Lophae) 4~12%
Radix Scrophulariae (Rodix Scrophulariar) 15~26%
The Radix Rehmanniae (Radix Rehmanniae) 12~24%
Rhizoma Coptidis (Rhizoma Coptidis) 3~10%
Radix Ophiopogonis (Radix Ophiopogonis) 4~12%
Folium Isatidis (Folium Isatidis) 6~16%
The each component summation is 100%
Its best composition scope percentage by weight is:
Herba Senecionis Scandentis 3~5%
Herba Artemisiae Annuae 3~5%
Herba Portulacae 4~6%
Flos Lonicerae 13~15%
Fructus Forsythiae 13~15%
Herba Lophatheri 6~7%
Radix Scrophulariae 19~21%
The Radix Rehmanniae 16~19%
Rhizoma Coptidis 5~6%
Radix Ophiopogonis 6~7%
Folium Isatidis 9~12%
The each component summation is 100%
The present invention can make decoction, also can make extractum.
Embodiment:
With Herba Senecionis Scandentis 6 gram, Herba Artemisiae Annuae 6 grams, Herba Portulacae 10 grams, Flos Lonicerae 20 grams, Fructus Forsythiae 20 grams, Herba Lophatheri 10 grams, Radix Scrophulariae 30 grams, the Radix Rehmanniae 25 grams, Rhizoma Coptidis 7 grams, Radix Ophiopogonis 10 gram, Folium Isatidis 15 grams put into water, surpass spice two horizontal finger degree of being with water, after the low baking temperature decoction, go medicinal residues the first road soup of decoction of the present invention, equally medicinal residues are decocted with water and remove slag into the second road soup, the patient divides early, eats up the first road soup and the second road soup respectively late twice every day, connects to eat and can fully recover in three days.
The present invention adopts common Chinese herbal medicine, and use is simple, convenient, the patient does not need hospitalization, and medical expense is low, and the mean treatment expenses for medicine is 18.2 yuan, and cure rate reached more than 98% in three days.
Claims (4)
1, a kind of pharmaceutical composition for the treatment of typhoid fever is characterized in that its composition scope percentage by weight is:
Herba Senecionis Scandentis: 1~8%, Herba Artemisiae Annuae: 1~8%, Herba Portulacae: 2~10%, Flos Lonicerae: 9~20%, Fructus Forsythiae: 9~20%, Herba Lophatheri: 4~12%, Radix Scrophulariae: 15~26%, the Radix Rehmanniae: 12~24%, Rhizoma Coptidis: 3~10%; Radix Ophiopogonis: 4~12%, Folium Isatidis: 6~16%, the each component summation is 100%.
2, a kind of pharmaceutical composition for the treatment of typhoid fever according to claim 1 is characterized in that its composition scope percentage by weight is:
Herba Senecionis Scandentis: 3~5%, Herba Artemisiae Annuae: 3~5%, Herba Portulacae: 4~6%, Flos Lonicerae: 13~15%, Fructus Forsythiae: 13~15%, Herba Lophatheri: 6~7%, Radix Scrophulariae: 19~21%, the Radix Rehmanniae: 16~19%, Rhizoma Coptidis: 5~6%, Radix Ophiopogonis: 6~7%, Folium Isatidis: 9~12%, each component always respectively is 100%.
3, the pharmaceutical composition of treatment typhoid fever according to claim 1 and 2 is characterized in that: it can make decoction.
4, the pharmaceutical composition of treatment typhoid fever according to claim 1 and 2 is characterized in that: it can make extractum.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94110874A CN1054043C (en) | 1994-03-12 | 1994-03-12 | Pharmaceutical composition for treating typhoid fever |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94110874A CN1054043C (en) | 1994-03-12 | 1994-03-12 | Pharmaceutical composition for treating typhoid fever |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1108559A CN1108559A (en) | 1995-09-20 |
CN1054043C true CN1054043C (en) | 2000-07-05 |
Family
ID=5034791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94110874A Expired - Fee Related CN1054043C (en) | 1994-03-12 | 1994-03-12 | Pharmaceutical composition for treating typhoid fever |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1054043C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058407C (en) * | 1996-08-13 | 2000-11-15 | 鞍山钢铁集团公司 | Medicament for treating gastropathy |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1073365A (en) * | 1992-11-23 | 1993-06-23 | 李法孔 | Chinese medicine dysentery spirit (Kowloon capsule) and compound method |
CN1073863A (en) * | 1991-12-30 | 1993-07-07 | 邓忠元 | The manufacture method of tablets for reducing enayme and replenishing liver |
-
1994
- 1994-03-12 CN CN94110874A patent/CN1054043C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1073863A (en) * | 1991-12-30 | 1993-07-07 | 邓忠元 | The manufacture method of tablets for reducing enayme and replenishing liver |
CN1073365A (en) * | 1992-11-23 | 1993-06-23 | 李法孔 | Chinese medicine dysentery spirit (Kowloon capsule) and compound method |
Non-Patent Citations (3)
Title |
---|
中西医结合杂志1991,11(3) 1991.3.31 薛中理等,中西医结合治疗伤寒580例疗效观察 * |
浙江中医杂志1990,25(8) 1990.8.31 姚昌礼等,小柴胡汤合三仁汤治疗湿温伤寒576例 * |
浙江中医杂志1990,25(8) 1990.8.31 姚昌礼等,小柴胡汤合三仁汤治疗湿温伤寒576例;中西医结合杂志1991,11(3) 1991.3.31 薛中理等,中西医结合治疗伤寒580例疗效观察 * |
Also Published As
Publication number | Publication date |
---|---|
CN1108559A (en) | 1995-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1824205A (en) | Medicine for treating chronic prostatitis and its preparation method | |
CN1130219C (en) | Litholysizing bear gall powder | |
CN1054043C (en) | Pharmaceutical composition for treating typhoid fever | |
CN1907353A (en) | Chinese traditional medicine preparation for treating chronic gastritis | |
CN1074285C (en) | Chinese medicine for curing appendicitis | |
CN100340284C (en) | Jindan gallbladder stone dissolving capsule | |
CN1181878C (en) | Detumescence plaster | |
CN1063088C (en) | Medicine for curing hepatic and gallbladder diseases | |
CN1186044C (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
CN1669571A (en) | Chinese traditional medicine for treating enteritis and appendicitis, and method for preparing same | |
CN1935211B (en) | Medicinal composition for treating cerebral ischemia | |
CN1616041A (en) | Chinese medicine composition for treating chronic ulcerative colitis | |
CN1093580A (en) | Medicine for treating toothache | |
CN1136899C (en) | Chinese medicine for treating mastoplasia | |
CN1435227A (en) | Medicament for treating lumbar and cervical vertebra pain | |
CN1872323A (en) | Drug tincture for treating flat wart, and preparation method | |
CN1322558A (en) | Liver cancer resisting medicine | |
CN1086954C (en) | Ganhuo mixture medicine for hepatosis | |
CN1255149C (en) | Combination of medication | |
CN1320449A (en) | Medicine for treating heart disease | |
CN1488372A (en) | Chinese medicine formual for treating heptitis | |
CN1686322A (en) | Blood fat reducing granules containing seed of pepper weed or flixweed tansymustard | |
CN1091024A (en) | Syrup for treating hepatitis | |
CN1616044A (en) | Chinese medicine composition for treating chronic hepatitis B | |
CN1163143A (en) | Medicine powder for curing hepatitis B |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |